Colony Forming Cell (CFC) Assays Predict for Increased Clinical Neutrophenia with Combination Therapies

Combination therapies are being increasingly employed to treat diseases where single agents do not have the desired clinical benefit. There are a number of publications that cite the benefit of combination therapy over monotherapy in preventing disease progression.